I migliori Terapia mirata di Terapia mirata - TOP-65medici

Specializzato in terapie mirate e immunoterapia oncologica – Il Dr. Karagöz apporta oltre 20 anni di esperienza in oncologia al Centro Medico Anadolu.

• Si concentra sulla biologia dei tumori e sull'immunologia
• Ha pubblicato oltre 40 articoli di ricerca negli studi sul cancro
• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul
• Membro dell'Associazione Turca di Oncologia Medica

La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso l'Anadolu Medical Center – classificato al 3° posto nell'esame di oncologia medica della Turchia.

• Oltre 12 anni di esperienza in oncologia medica
• Formazione completata presso l'Università di Marmara – un centro leader in oncologia
• Ha guidato studi clinici internazionali nei trattamenti oncologici
• Ex capo dell'oncologia medica presso l'Ospedale Haydarpaşa Numune

Il Dott. Solak è specializzato in terapie mirate per diversi tipi di cancro, formato presso l'Istituto Oncologico dell'Università di Hacettepe e il MD Anderson Cancer Center.

• Esperto in tumori della mammella, testicolari, ovarici, polmonari e gastrointestinali
• Ha completato il fellowship presso il prestigioso Istituto Oncologico dell'Università di Hacettepe
• Ha lavorato presso il MD Anderson Cancer Center dell'Università del Texas
• Gestisce casi complessi con piani di trattamento personalizzati

La Dott.ssa Sharon Pelles è un'oncologa rispettata con ampia esperienza in terapie mirate e altri trattamenti avanzati per il cancro presso il Sourasky Medical Center.

• Specializzata in terapie mirate per vari tipi di cancro
• Ha contribuito alla ricerca clinica sulle attitudini dei pazienti oncologici nei confronti delle sperimentazioni
• Esegue numerosi trattamenti avanzati per il cancro, tra cui la terapia SIRT e la HIPEC
• Lavora presso il Sourasky Medical Center (Ichilov), un ospedale israeliano all'avanguardia

Il medico è un neurochirurgo rinomato in Germania e in Europa, riconosciuto per la sua esperienza nelle patologie dei dischi intervertebrali, paralisi cerebrale e disturbi del sistema nervoso periferico. Il medico esegue interventi chirurgici per tumori cerebrali maligni e anomalie vascolari. <\/p>

Come Dottore in Scienze Mediche, il medico è attivamente coinvolto nella ricerca, con pubblicazioni su riviste mediche europee. Solo nel 2016, il medico ha pubblicato 47 articoli scientifici, con un focus su neuropatologia e chirurgia delle metastasi cerebrali. <\/p>

Il medico è cofondatore di un fondo dedicato alla ricerca sui tumori cerebrali e si specializza in tecniche minimamente invasive, microchirurgiche ed endoscopiche.<\/p>

Il Professor Ofer Merimsky guida l'unità di Oncologia dei Tessuti Molli e Ossea presso il Sourasky Medical Center – il principale specialista in sarcomi di Israele.

• Oltre 30 anni di esperienza nel trattamento dei sarcomi con terapie mirate
• Fellowship in sarcomi presso l'Institut Gustave Roussy, Parigi
• Membro della facoltà ESMO per la ricerca sui sarcomi
• Ha pubblicato ampiamente sull'oncologia ortopedica
• Ex Presidente della Società di Oncologia d'Israele

Il Dr. Sarid ha pubblicato oltre 30 articoli sulla terapia del cancro e guida studi clinici sui trattamenti mirati presso il Sourasky Medical Center.

• Specializzato in chemioterapia, radioterapia e terapia biologica per diversi tipi di cancro
• Oltre 15 anni come oncologo senior presso l'Ichilov Medical Center
• Docente presso l'Università di Tel Aviv – si mantiene aggiornato sulle terapie più recenti
• Membro dell'ESMO e dell'ASCO – segue le linee guida internazionali per i trattamenti

Il medico è specializzato in ginecologia oncologica e radioterapia, concentrandosi sul trattamento e la gestione dei tumori ginecologici. Con un'ampia esperienza nelle tecniche avanzate di radioterapia, il medico ha contribuito a migliorare i risultati dei pazienti attraverso approcci innovativi nella cura del cancro. Il medico è riconosciuto per il suo impegno nell'integrare la ricerca all'avanguardia nella pratica clinica, garantendo che i pazienti ricevano i trattamenti più efficaci e aggiornati disponibili.<\/p>

Dr. Andrej Orságh is a gastroenterologist, certified in 2015. He has worked at the Gastroenterology Department of the National Cancer Institute (NOÚ) since 2016. Since 2019 he has been the institute’s specialist consultant for colorectal cancer screening. He leads the colorectal cancer screening working group of the Slovak Gastroenterological Society. He is vice-chair of its Endoscopy Section and chair of its Oncology Section.

He graduated from Comenius University in 2009. He trained at the Gastroenterology Clinic of the University Hospital in Bratislava and at the Slovak Medical University. He shares his expertise at professional conferences and in publications. He also teaches basic and advanced endoscopic techniques in NOÚ courses.

Dr. Juraj Letkovsky has been a gastroenterologist at the Gastroenterology Department of the National Cancer Institute (NOÚ) since 2017. He graduated in medicine in 2012 and earned a PhD in internal medicine in 2016. He obtained specialization in gastroenterology in 2018.

His practice focuses on advanced endoscopic diagnosis and treatment of digestive tract tumors. He performs endosonography and ERCP for pancreatic and biliary diseases.

He serves on the Young Gastroenterologists, Endoscopy, and Oncology sections of the Slovak Gastroenterology Society. He is a co-author of an ongoing multicenter study on colonoscopy quality in Slovakia. He holds certificates in diagnostic and interventional esophagogastroduodenoscopy (2022) and endoscopic retrograde cholangiopancreatography (2023).

Dr. Boris Pekárek is a gastroenterologist. He graduated from the Faculty of Medicine, Comenius University in Bratislava in 2002. He worked at the Internal Medicine Clinic in Trnava from 2002 to April 2010. He obtained his specialization in gastroenterology in 2008.

Since April 2010, he has worked at the Gastroenterology Department of the National Cancer Institute. He has led the department since 2017. He completed several specialized training courses abroad. He focuses on endoscopic diagnosis and treatment of early tumors of the esophagus, stomach, colon, and rectum.

He served as chair of the Oncology Section of the Slovak Gastroenterological Society from 2018 to 2024. He is the current chair of its Endoscopy Section and a member of the Society’s committee. He publishes, lectures at conferences, and trains basic and advanced endoscopic techniques in Slovakia and abroad.

Dr. Lubos Zitnan is a gastroenterologist at the Gastroenterology Department of the National Cancer Institute. He has worked there since 2010. He also serves on the committee of the Oncology Section of the Slovak Gastroenterological Society.

His practice includes colonoscopy, gastroscopy, endosonography (EUS), and ERCP for pancreatic and biliary diseases. He holds certificates in diagnostic and interventional esophagogastroduodenoscopy, diagnostic and interventional colonoscopy, and endoscopic retrograde cholangiopancreatography.

He graduated from the Faculty of Medicine, Comenius University, in 2003. He completed an internal medicine residency at Malacky Hospital. He began specialized training in gastroenterology at the National Cancer Institute in 2007.

Dr. Daniela Osuská is a gastroenterologist. She graduated from the First Faculty of Medicine, Charles University, in 2010. From 2010 to 2019 she worked as a secondary physician at the Internal Medicine Clinic of Nitra University Hospital. There she began performing endoscopies. Since 2019 she has worked at the Gastroenterology Department of the National Cancer Institute. She earned her gastroenterology specialization in 2021.

She serves on the supervisory board of the Oncology Section of the Slovak Gastroenterological Society and the Section of Young Gastroenterologists. She publishes and presents her work in Slovakia and abroad. She also trains physicians in endoscopic techniques.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

Il medico è un oncologo pediatrico premiato, specializzato in sarcomi ossei e dei tessuti molli. Come capo del Dipartimento di Ematologia Oncologica presso Sant Joan De Déu, un ospedale pediatrico leader in Europa, il medico fornisce trattamenti per neuroblastomi, gliomi, sarcomi di Ewing e tumori di Wilms.<\/p>

Formatosi negli Stati Uniti, il medico ha completato borse di studio in ematologia oncologica pediatrica e patologia molecolare del cancro pediatrico presso Weill Cornell Medicine e Memorial Sloan Kettering Cancer Center. Il medico ha scritto oltre 70 articoli e ha sviluppato un trattamento non radiativo per i gliomi del midollo spinale.<\/p>

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Il medico è specializzato nella gestione del cancro al seno, del colon-retto e dei tumori del sistema urogenitale. Con un'ampia esperienza dal 2014 presso l'Anadolu Medical Center, il medico ha precedentemente lavorato presso il Medical Park Hospital, l'Ospedale di Educazione e Ricerca Kocaeli Derince e l'Ospedale Regionale di Educazione e Ricerca di Erzurum. Il servizio militare del medico includeva un ruolo come specialista in Oncologia Medica presso l'Accademia Medica Militare di Gülhane.<\/p>

I successi educativi includono una laurea in medicina generale presso l'Università di Istanbul e specializzazioni in medicina interna e oncologia medica. Il medico è membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro del Polmone.<\/p>

Classificato al 1º posto nell'Esame di Competenza in Oncologia Medica della Turchia – Il Dott. Keskin è specializzato in terapia mirata presso il Memorial Şişli Hospital.

• Oltre 28 anni di esperienza in oncologia
• Vincitore del premio per il miglior poster al Congresso Nazionale sul Cancro
• Membro dell'ASCO e dell'ESMO
• Formazione presso l'Istituto di Oncologia dell'Università di Istanbul